ARCHIVES

Preventive Services Task Force Urges Colorectal Cancer Screening for 50 and Up; Advises Against Tamoxifen for Women at Low to Average Breast Cancer Risk

This article is from The Cancer Letter archive.

Vol. 28 No. 29 | July 19, 2002

Download PDF Visit The Full Archive

Related Articles

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

AACI Summarizes Position On New Core Guidelines

May 16, 1980

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003

CMS Withholds Coverage of CT Colonography

May 15, 2009

NCI-Approved Clinical Trials

February 23, 2007